Edwards Lifesciences Long Term Debt 2010-2024 | EW

Edwards Lifesciences long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Edwards Lifesciences long term debt for the quarter ending March 31, 2024 was $0.597B, a 0.12% increase year-over-year.
  • Edwards Lifesciences long term debt for 2023 was $0.597B, a 0.12% increase from 2022.
  • Edwards Lifesciences long term debt for 2022 was $0.596B, a 0.1% increase from 2021.
  • Edwards Lifesciences long term debt for 2021 was $0.596B, a 0.12% increase from 2020.
Edwards Lifesciences Annual Long Term Debt
(Millions of US $)
2023 $597
2022 $596
2021 $596
2020 $595
2019 $594
2018 $594
2017 $438
2016 $822
2015 $597
2014 $598
2013 $593
2012 $189
2011 $150
2010 $
2009 $90
Edwards Lifesciences Quarterly Long Term Debt
(Millions of US $)
2024-03-31 $597
2023-12-31 $597
2023-09-30 $597
2023-06-30 $597
2023-03-31 $597
2022-12-31 $596
2022-09-30 $596
2022-06-30 $596
2022-03-31 $596
2021-12-31 $596
2021-09-30 $596
2021-06-30 $595
2021-03-31 $595
2020-12-31 $595
2020-09-30 $595
2020-06-30 $595
2020-03-31 $595
2019-12-31 $594
2019-09-30 $594
2019-06-30 $594
2019-03-31 $594
2018-12-31 $594
2018-09-30 $594
2018-06-30 $594
2018-03-31 $456
2017-12-31 $438
2017-09-30 $1,034
2017-06-30 $1,017
2017-03-31 $848
2016-12-31 $822
2016-09-30 $601
2016-06-30 $603
2016-03-31 $602
2015-12-31 $597
2015-09-30 $605
2015-06-30 $600
2015-03-31 $603
2014-12-31 $598
2014-09-30 $596
2014-06-30 $598
2014-03-31 $725
2013-12-31 $593
2013-09-30 $532
2013-06-30 $227
2013-03-31 $193
2012-12-31 $189
2012-09-30 $175
2012-06-30 $185
2012-03-31 $179
2011-12-31 $150
2011-09-30 $175
2011-06-30 $175
2011-03-31
2010-12-31
2010-09-30
2010-06-30 $178
2010-03-31 $129
2009-12-31 $90
2009-09-30 $102
2009-06-30 $114
2009-03-31 $123
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $54.361B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.518B 27.33
Intuitive Surgical (ISRG) United States $142.199B 85.66
DexCom (DXCM) United States $51.910B 78.63
Alcon (ALC) Switzerland $44.749B 32.07
IDEXX Laboratories (IDXX) United States $42.775B 50.14
IQVIA Holdings (IQV) United States $41.183B 23.89
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.691B 30.41
SONOVA HOLDING (SONVY) Switzerland $18.917B 0.00
Hologic (HOLX) United States $17.459B 19.53
ShockWave Medical (SWAV) United States $12.540B 78.04
Fresenius Medical Care AG KGaA (FMS) Germany $12.235B 14.28
Sysmex ADR (SSMXY) Japan $10.844B 34.01
Teleflex (TFX) United States $10.037B 15.62
Globus Medical (GMED) United States $9.090B 26.65
Penumbra (PEN) United States $7.713B 87.65
Masimo (MASI) United States $6.721B 38.72
Glaukos (GKOS) United States $5.426B 0.00
TransMedics (TMDX) United States $4.511B 428.03
Integer Holdings (ITGR) United States $4.073B 24.61
PROCEPT BioRobotics (PRCT) United States $3.449B 0.00
Tandem Diabetes Care (TNDM) United States $3.319B 0.00
LivaNova (LIVN) United Kingdom $3.280B 19.48
Elekta AB (EKTAY) Sweden $3.078B 21.12
Inari Medical (NARI) United States $2.771B 0.00
Nihon Kohden (NHNKY) Japan $2.493B 21.08
RxSight (RXST) United States $2.285B 0.00
Integra LifeSciences Holdings (IART) United States $2.216B 9.66
Veracyte (VCYT) United States $1.653B 0.00
Alphatec Holdings (ATEC) United States $1.505B 0.00
Artivion (AORT) United States $0.991B 95.04
AVANOS MEDICAL, INC (AVNS) United States $0.935B 18.18
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.878B 0.00
OrthoPediatrics (KIDS) United States $0.790B 0.00
Pulse Biosciences (PLSE) United States $0.659B 0.00
Paragon 28 (FNA) United States $0.653B 0.00
Mesa Laboratories (MLAB) United States $0.617B 20.94
SiBone (SIBN) United States $0.578B 0.00
IRadimed (IRMD) United States $0.551B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.504B 0.00
Nevro (NVRO) United States $0.360B 0.00
Treace Medical Concepts (TMCI) United States $0.331B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.50
AxoGen (AXGN) United States $0.271B 0.00
Sight Sciences (SGHT) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.253B 0.00
908 Devices (MASS) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Delcath Systems (DCTH) United States $0.218B 0.00
Inogen (INGN) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.184B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.165B 8.37
Accuray (ARAY) United States $0.152B 0.00
Yubo Biotech (YBGJ) China $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.096B 20.10
Neuronetics (STIM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
DarioHealth (DRIO) United States $0.052B 0.00
Autonomix Medical (AMIX) United States $0.048B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00